Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorNational Taiwan University Hospital

About this trial

Glutamine has the potentials of immunomodulation and adjustment of protein metabolism. The primary objective of this study is to evaluate the efficacy of glutamine on sarcopenia in gastric adenocarcinoma patients undergoing gastrectomy. The secondary endpoints, including the physical activity, weight loss, and nutritional profiles, will be evaluated among these patients.

Eligibility criteria

Qualifiers

adult gastric cancer receiving gastrectomy

Disqualifiers

Hepatic insufficiency

Renal insufficiency

can not tolerate oral or enteral feeding 7 days after gastrectomy

can not receive computed tomograph

Trial design

Treatments tested in this trial

  • oral glutamine
  • Maltodextrin

Treatment groups

120 Participants
are divided into 2 treatment groups